Robert A. Baiocchi

Research activity per year

Filter

2024
Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530] (Clinical Lymphoma, Myeloma and Leukemia (2024) 24(8) (523–530), (S2152265024001344), (10.1016/j.clml.2024.03.011))
Lurain, K., El Zarif, T., Ramaswami, R., Nassar, A. H., Adib, E., Abdel-Wahab, N., Chintapally, N., Drolen, C. E., Feldman, T., Haykal, T., Nebhan, C. A., Kambhampati, S., Li, M., Mittra, A., Lorentsen, M., Kim, C., Drakaki, A., Morse, M., Johnson, D. B. & Mangla, A. & 10 others, Dittus, C., Ravi, P., Baiocchi, R. A., Chiao, E. Y., Rubinstein, P. G., Yellapragada, S. V., LaCasce, A. S., Sonpavde, G. P., Naqash, A. R. & Herrera, A. F., Dec 2024, In: Clinical Lymphoma, Myeloma and Leukemia. 24, 12, p. 873 1 p.
Research output: Contribution to journal › Comment/debate
2014
Driving toward targeted therapy for LCH
Baiocchi, R. A., 2014, In: Blood. 124, 10, p. 1546-1548 3 p.
Research output: Contribution to journal › Comment/debate

Open Access
4 Scopus citations

Research output